强化血液透析与肾移植受者妊娠结局的比较
该回顾性队列研究比较了2000至2023年间在多伦多同一多学科团队管理下,接受强化血液透析的37名女性(48次妊娠)与肾移植后受孕的60名女性(96次妊娠)的妊娠结局。两组活产率相似(80% vs 76%,P=0.68),但透析组妊娠期更短、新生儿出生体重更低。研究表明,在适当咨询和管理下,对于无即刻供肾来源的女性,透析期间妊娠或可作为移植后受孕的可行替代方案。
要点
- 强化血透与肾移植受者活产率相似(80% vs 76%,P=0.68)。
- 血透组妊娠期更短(36.2周 vs 37.0周,P=0.004),新生儿体重更低(2202g vs 2766g,P<0.001)。
- 两组妊娠相关并发症比例无差异(67% vs 73%,P=0.53)。
核心结论
- 对于无即刻供肾来源的女性,经适当咨询和管理,透析期间妊娠或可考虑为移植后受孕的可行替代方案。
研究设计与样本
- 2000至2023年在加拿大安大略省多伦多开展的回顾性队列研究,比较强化血液透析女性与肾移植受者的妊娠结局。
- 纳入37名血透女性的48次妊娠和60名肾移植受者的96次妊娠,两组由同一多学科团队管理。
主要发现
- 活产率血透组80%、移植组76%,差异无统计学意义(P=0.68)。
- 血透组妊娠期较短(36.2周,IQR 32.5-37.1 vs 37.0周,IQR 35.7-38.0;P=0.004)。
- 血透组新生儿出生体重较低(2202 g,IQR 1600-2750 vs 2766 g,IQR 2380-3180;P<0.001)。
- 妊娠相关并发症比例两组无差异(67% vs 73%,P=0.53),妊娠期高血压疾病分别为33%和47%(P=0.18)。
临床怎么用
- 对无即刻供肾来源的透析女性,经多学科团队咨询和管理,可考虑妊娠作为移植前的一种选择。
- 需告知血透妊娠者早产和低出生体重风险较高,加强监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Tailored hemodialysis prescriptions, including more frequent and intensive regimens, may improve pregnancy outcomes, yet most women are counselled to delay conception until after a successful kidney transplantation. METHODS: We conducted a retrospective cohort study between 2000 and 2023 in Toronto, Ontario, Canada to compare pregnancy outcomes of women receiving intensified hemodialysis versus kidney transplant recipients. RESULTS: We included 48 pregnancies in 37 women receiving hemodialysis and 96 pregnancies in 60 women conceiving post-kidney transplantation. The 2 patient populations managed by the same multidisciplinary team had similar live birth rates (80% in hemodialysis and 76% in transplant patients; P = 0.68). However, the hemodialysis cohort had a shorter pregnancy duration (36.2 weeks; interquartile range [IQR]: 32.5-37.1 vs. 37.0 weeks; IQR; 35.7-38.0; P = 0.004) and smaller infants at birth (2202 g; IQR: 1600-2750 vs. 2766 g; IQR: 2380-3180; P < 0.001). No difference was observed in the proportion of pregnancies with reported pregnancy-associated complications (67% in hemodialysis and 73% in transplant; P = 0.53), including hypertensive disorders of pregnancy at 33% in the hemodialysis cohort and 47% among transplant recipients (P = 0.18). CONCLUSION: With appropriate counselling and management, pregnancy while on hemodialysis may be considered a viable alternative to conceiving post-renal transplant for women without imminent access to a donor.
引用
- Bhasin AA, D'Souza R, Hui D, et al. A Comparison of Pregnancy Outcomes in Women Receiving Intensive Hemodialysis Versus Kidney Transplant Recipients. Kidney Int Rep. 2025. PMID: 41660591. doi:10.1016/j.ekir.2025.103722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。